171 related articles for article (PubMed ID: 24972190)
1. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.
Laskov I; Drudi L; Beauchamp MC; Yasmeen A; Ferenczy A; Pollak M; Gotlieb WH
Gynecol Oncol; 2014 Sep; 134(3):607-14. PubMed ID: 24972190
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
3. Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.
Niraula S; Dowling RJ; Ennis M; Chang MC; Done SJ; Hood N; Escallon J; Leong WL; McCready DR; Reedijk M; Stambolic V; Goodwin PJ
Breast Cancer Res Treat; 2012 Oct; 135(3):821-30. PubMed ID: 22933030
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
Soliman PT; Zhang Q; Broaddus RR; Westin SN; Iglesias D; Munsell MF; Schmandt R; Yates M; Ramondetta L; Lu KH
Gynecol Oncol; 2016 Dec; 143(3):466-471. PubMed ID: 27745917
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.
Bonanni B; Puntoni M; Cazzaniga M; Pruneri G; Serrano D; Guerrieri-Gonzaga A; Gennari A; Trabacca MS; Galimberti V; Veronesi P; Johansson H; Aristarco V; Bassi F; Luini A; Lazzeroni M; Varricchio C; Viale G; Bruzzi P; Decensi A
J Clin Oncol; 2012 Jul; 30(21):2593-600. PubMed ID: 22564993
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
8. Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
Hadad S; Iwamoto T; Jordan L; Purdie C; Bray S; Baker L; Jellema G; Deharo S; Hardie DG; Pusztai L; Moulder-Thompson S; Dewar JA; Thompson AM
Breast Cancer Res Treat; 2011 Aug; 128(3):783-94. PubMed ID: 21655990
[TBL] [Abstract][Full Text] [Related]
9. Effect of Metformin For Decreasing Proliferative Marker in Women with Endometrial Cancer: A Randomized Double-blind Placebo-Controlled Trial.
Petchsila K; Prueksaritanond N; Insin P; Yanaranop M; Chotikawichean N
Asian Pac J Cancer Prev; 2020 Mar; 21(3):733-741. PubMed ID: 32212801
[TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
[TBL] [Abstract][Full Text] [Related]
11. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
[TBL] [Abstract][Full Text] [Related]
13. PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial.
Kitson SJ; Maskell Z; Sivalingam VN; Allen JL; Ali S; Burns S; Gilmour K; Latheef R; Slade RJ; Pemberton PW; Shaw J; Ryder WD; Kitchener HC; Crosbie EJ
Clin Cancer Res; 2019 Apr; 25(8):2424-2432. PubMed ID: 30563932
[TBL] [Abstract][Full Text] [Related]
14. Measuring the biological effect of presurgical metformin treatment in endometrial cancer.
Sivalingam VN; Kitson S; McVey R; Roberts C; Pemberton P; Gilmour K; Ali S; Renehan AG; Kitchener HC; Crosbie EJ
Br J Cancer; 2016 Feb; 114(3):281-9. PubMed ID: 26794276
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
[TBL] [Abstract][Full Text] [Related]
17. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
18. Metformin is associated with improved survival in endometrial cancer.
Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
[TBL] [Abstract][Full Text] [Related]
19. Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.
Campagnoli C; Pasanisi P; Abbà C; Ambroggio S; Biglia N; Brucato T; Colombero R; Danese S; Donadio M; Venturelli E; Zito G; Berrino F
Clin Breast Cancer; 2012 Jun; 12(3):175-82. PubMed ID: 22607767
[TBL] [Abstract][Full Text] [Related]
20. A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.
Joshua AM; Zannella VE; Downes MR; Bowes B; Hersey K; Koritzinsky M; Schwab M; Hofmann U; Evans A; van der Kwast T; Trachtenberg J; Finelli A; Fleshner N; Sweet J; Pollak M
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):252-8. PubMed ID: 24861559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
